Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Total Debt: 2019-2025

Historic Total Debt for China SXT Pharmaceuticals (SXTC) over the last 7 years, with Mar 2025 value amounting to $798,448.

  • China SXT Pharmaceuticals' Total Debt fell 98.64% to $102,601 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 8.19%. This contributed to the annual value of $798,448 for FY2025, which is 30.85% up from last year.
  • As of FY2025, China SXT Pharmaceuticals' Total Debt stood at $798,448, which was up 30.85% from $610,183 recorded in FY2024.
  • China SXT Pharmaceuticals' Total Debt's 5-year high stood at $12.2 million during FY2021, with a 5-year trough of $11,404 in FY2022.
  • For the 3-year period, China SXT Pharmaceuticals' Total Debt averaged around $564,649, with its median value being $610,183 (2024).
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Total Debt slumped by 99.91% in 2022, and later surged by 2,401.89% in 2023.
  • Over the past 5 years, China SXT Pharmaceuticals' Total Debt (Yearly) stood at $12.2 million in 2021, then slumped by 99.91% to $11,404 in 2022, then skyrocketed by 2,401.89% to $285,315 in 2023, then spiked by 113.86% to $610,183 in 2024, then spiked by 30.85% to $798,448 in 2025.